×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| ORTIN GLOBAL LIMITED | 0.86 | -1.64 | 0.45 | -0.20 | 9.06 | |
| DR LALCHANDANI LABS LIMITED | NA | NA | NA | NA | 8.92 | 21.2 |
| DHANVANTRI JEEVAN REKHA LTD. | 59.40 | 0.30 | 58.30 | 0.45 | 8.71 | 17.1 |
Ortin Laboratories Limited, with Security Code 539287, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.2 | 1.5 | 1.6 | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 |
| Expenses | 0.5 | 1.5 | 1.4 | 1.2 | 2.7 | 3.4 | 0.3 | 0.5 | 0.1 | 0.2 |
| Operating Profit | 0.6 | -0.1 | 0.2 | -0.9 | -2.6 | -3.2 | -0.1 | -0.4 | -0.1 | -0.2 |
| OPM % | 52.72% | -4.19% | 11.84% | -346.92% | -1913.97% | -2219.31% | -47.37% | -816.36% | -302.94% | -344.44% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.4 | -0.2 | 0.0 | -1.1 | -2.8 | -3.2 | -0.1 | -0.5 | -0.1 | -0.1 |
| Tax % | 1.6% | -2.7% | 6.3% | 1.4% | -0.6% | 30.4% | -2% | 0.2% | 5.9% | 0% |
| Net Profit | 0.5 | -0.2 | 0.0 | -1.1 | -2.8 | -4.1 | -0.1 | -0.5 | -0.1 | -0.2 |
| EPS in Rs | 0.56 | -0.22 | 0.02 | -1.38 | -3.43 | -5.1 | 0 | -0.58 | -0.13 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -29% |
| 5 Years: | -58% |
| 3 Years: | -36% |
| TTM: | -83% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -1% |
| 3 Years: | -24% |
| 1 Year: | -36% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -1% |
| 3 Years: | -24% |
| 1 Year: | -36% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|